{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-cybersecurity-and-privacy-in-decentralized-trials”
},
“headline”: “SOP for Cybersecurity and Privacy in Decentralized Trials”,
“description”: “This SOP defines procedures for ensuring cybersecurity and data privacy in decentralized clinical trials. It establishes controls for secure platforms, encryption, user access management, data protection, and compliance with FDA, EMA, GDPR, HIPAA, CDSCO, WHO, and ICH GCP guidelines.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}
Published on 25/12/2025
Standard Operating Procedure for Cybersecurity and Privacy in Decentralized Trials
| SOP No. | CR/OPS/125/2025 |
| Supersedes | NA |
| Page No. | 1 of 72 |
| Issue Date | 26/08/2025 |
| Effective Date | 01/09/2025 |
| Review Date | 01/09/2026 |
Purpose
The purpose of this SOP is to define cybersecurity and privacy measures for decentralized clinical trials. It establishes controls
Scope
This SOP applies to sponsors, CROs, investigators, site staff, IT vendors, and QA teams involved in decentralized and hybrid clinical trials. It covers secure system design, encryption, authentication, monitoring, incident management, and compliance with HIPAA, GDPR, FDA Part 11, and ICH GCP.
Responsibilities
- Sponsor: Ensures cybersecurity systems are validated and vendors comply with requirements.
- Investigator: Ensures confidentiality of subject data collected remotely.
- CRO: Oversees decentralized platform security and audits vendors.
- IT Vendor: Provides secure infrastructure with validated encryption and monitoring systems.
- QA: Audits cybersecurity and privacy systems for compliance.
- Data Protection Officer: Ensures GDPR/HIPAA compliance and handles breach notifications.
Accountability
The Sponsor’s Chief Information Security Officer (CISO) is accountable for cybersecurity systems in decentralized trials. Investigators remain accountable for subject data collected at the site or remotely.
Procedure
1. System Validation
1.1 Validate IT systems for Part 11/GDPR compliance.
1.2 Record in System Validation Log (Annexure-1).
2. Encryption
2.1 Use end-to-end encryption for all subject data transmissions.
2.2 Maintain Encryption Log (Annexure-2).
3. User Authentication and Access Control
3.1 Implement multi-factor authentication (MFA).
3.2 Assign role-based access controls.
3.3 Maintain User Access Log (Annexure-3).
4. Cybersecurity Monitoring
4.1 Monitor systems for unauthorized access and breaches.
4.2 Maintain Monitoring Log (Annexure-4).
5. Incident Reporting
5.1 Report cybersecurity incidents within 24 hours.
5.2 Record incidents in Incident Log (Annexure-5).
5.3 Notify regulators per GDPR/HIPAA requirements.
6. Staff Training
6.1 Conduct regular cybersecurity and privacy training.
6.2 Maintain Training Log (Annexure-6).
7. Audit and Inspection Readiness
7.1 Conduct periodic audits of cybersecurity measures.
7.2 Maintain Audit Log (Annexure-7).
8. Archiving
8.1 Archive cybersecurity logs and incident reports in TMF and ISF.
8.2 Retain per regulatory timelines.
Abbreviations
- SOP: Standard Operating Procedure
- CRO: Contract Research Organization
- QA: Quality Assurance
- CISO: Chief Information Security Officer
- TMF: Trial Master File
- ISF: Investigator Site File
- GDPR: General Data Protection Regulation
- HIPAA: Health Insurance Portability and Accountability Act
- FDA: Food and Drug Administration
- EMA: European Medicines Agency
- CDSCO: Central Drugs Standard Control Organization
Documents
- System Validation Log (Annexure-1)
- Encryption Log (Annexure-2)
- User Access Log (Annexure-3)
- Monitoring Log (Annexure-4)
- Incident Log (Annexure-5)
- Training Log (Annexure-6)
- Audit Log (Annexure-7)
References
- FDA – Cybersecurity Guidance
- EMA – Digital Health and Cybersecurity
- CDSCO – Data Security in Clinical Trials
- GDPR – Data Protection Regulation
- HIPAA – Privacy and Security Rules
- ICH GCP – Data Integrity Standards
- WHO – Digital Health Guidelines
Version: 1.0
Approval Section
| Prepared By | Ravi Kumar, IT Security Specialist |
| Checked By | Sunita Reddy, QA Officer |
| Approved By | Dr. Anil Sharma, Head Clinical Operations |
Annexures
Annexure-1: System Validation Log
| Date | System | Validation Status | Reviewed By |
|---|---|---|---|
| 01/09/2025 | Decentralized Trial Platform v5.0 | Validated | QA Officer |
Annexure-2: Encryption Log
| Date | System | Encryption Type | Reviewed By |
|---|---|---|---|
| 02/09/2025 | Trial Database | AES-256 | IT Security |
Annexure-3: User Access Log
| Date | User ID | Role | Access Level | Status |
|---|---|---|---|---|
| 03/09/2025 | MON-01 | Monitor | Read Only | Active |
Annexure-4: Monitoring Log
| Date | System | Activity Monitored | Reviewed By | Status |
|---|---|---|---|---|
| 04/09/2025 | Trial Platform | Unauthorized Access Attempts | CISO | Blocked |
Annexure-5: Incident Log
| Date | Incident | Impact | Action Taken | Status |
|---|---|---|---|---|
| 05/09/2025 | Suspicious Login | Low | Blocked and Investigated | Closed |
Annexure-6: Training Log
| Date | Staff Name | Training Topic | Trainer | Status |
|---|---|---|---|---|
| 06/09/2025 | Site Staff | Cybersecurity Awareness | IT Security | Completed |
Annexure-7: Audit Log
| Date | System | Audit Type | Auditor | Status |
|---|---|---|---|---|
| 07/09/2025 | Trial Platform | Quarterly Cybersecurity Audit | QA Team | Completed |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 26/08/2025 | 00 | Initial version | New SOP creation | Head Clinical Operations |
For more SOPs visit: Pharma SOP